Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00593723 · ClinicalTrials.gov registry record · Phase 1
IMRT Tomotherapy for Esophagus Cancer
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00593723 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 26 participants.
The verdict
NCT00593723, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
Concurrent chemotherapy and radiation therapy are the standard of care for inoperable patients with esophagus cancer. Unfortunately, the 5-year survival of 20% for this population is quite low. Methods to intensify radiation therapy delivery without increasing local toxicities are needed. Intensity modulated radiation therapy (IMRT) is an advanced method of delivering external beam radiation that may minimize the volume of normal tissue irradiated to high dose and thus decrease the risk of normal tissue toxicity. The proposed study will prospectively test whether IMRT is tolerable for delivering IMRT doses of 60 Gy for patients with esophagus cancer.
Interventions
- RADIATION IMRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-12 |
| Est. Completion | 2015-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00593723
The ClinicalTrials.gov registry entry for NCT00593723 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IMRT is the first listed.
NCT00593723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00593723 about?
NCT00593723 is a clinical study titled "IMRT Tomotherapy for Esophagus Cancer". Concurrent chemotherapy and radiation therapy are the standard of care for inoperable patients with esophagus cancer. Unfortunately, the 5-year survival of 20% for this population is quite low. Methods to intensify radiation therapy delivery without increasing local toxicities are needed. Intensity ...
What is the current status of trial NCT00593723?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2006-12. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00593723?
The interventions under investigation include: IMRT (RADIATION).
Who is sponsoring clinical trial NCT00593723?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.